Efficacy and Safety of Combining Apremilast 30mg Bid With Narrowband UVB in the Treatment of Moderate-to-severe Plaque Psoriasis
Phase of Trial: Phase IV
Latest Information Update: 22 Jul 2016
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 19 Jul 2016 Status changed from recruiting to completed.
- 27 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Oct 2015 to 1 Feb 2016.
- 27 Jul 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Oct 2015 to 1 Dec 2015.